DK172788B1 - Anvendelse af castanosperminestere til fremstilling af et farmaceutisk præparat - Google Patents

Anvendelse af castanosperminestere til fremstilling af et farmaceutisk præparat Download PDF

Info

Publication number
DK172788B1
DK172788B1 DK198805388A DK538888A DK172788B1 DK 172788 B1 DK172788 B1 DK 172788B1 DK 198805388 A DK198805388 A DK 198805388A DK 538888 A DK538888 A DK 538888A DK 172788 B1 DK172788 B1 DK 172788B1
Authority
DK
Denmark
Prior art keywords
acid
castanospermine
preparation
pharmaceutical composition
octahydro
Prior art date
Application number
DK198805388A
Other languages
Danish (da)
English (en)
Other versions
DK538888A (da
DK538888D0 (da
Inventor
Paul S Liu
Terry L Bowlin
Sai P Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK538888D0 publication Critical patent/DK538888D0/da
Publication of DK538888A publication Critical patent/DK538888A/da
Application granted granted Critical
Publication of DK172788B1 publication Critical patent/DK172788B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK198805388A 1987-09-29 1988-09-28 Anvendelse af castanosperminestere til fremstilling af et farmaceutisk præparat DK172788B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/102,070 US5004746A (en) 1987-09-29 1987-09-29 Anti-retroviral castanospermine esters
US10207087 1987-09-29

Publications (3)

Publication Number Publication Date
DK538888D0 DK538888D0 (da) 1988-09-28
DK538888A DK538888A (da) 1989-03-30
DK172788B1 true DK172788B1 (da) 1999-07-19

Family

ID=22287973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198805388A DK172788B1 (da) 1987-09-29 1988-09-28 Anvendelse af castanosperminestere til fremstilling af et farmaceutisk præparat

Country Status (12)

Country Link
US (1) US5004746A (de)
EP (1) EP0309952B1 (de)
JP (1) JP2761898B2 (de)
KR (1) KR960009416B1 (de)
AT (1) ATE107506T1 (de)
AU (1) AU614993B2 (de)
DE (1) DE3850335T2 (de)
DK (1) DK172788B1 (de)
ES (1) ES2058201T3 (de)
IE (1) IE64311B1 (de)
PH (1) PH24431A (de)
ZA (1) ZA887160B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252962B1 (de) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulierung der retroviralen replikation, infektion und pathogenese
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis
AU628228B2 (en) * 1989-10-17 1992-09-10 Merrell Dow Pharmaceuticals Inc. Esters of castanospermine in the treatment of cerebral malaria
US5214050A (en) * 1989-10-17 1993-05-25 Merrell Dow Pharmaceuticals Inc. Esters of castanospermine in the treatment of cerebral malaria
GB8924292D0 (en) * 1989-10-27 1989-12-13 Novalal Ltd The production of a novel dimer chemical product"novo dimers"by the polymersation of indolizidine alkaloids using cyclo dextrin glucosyl transferase
US5028614A (en) * 1990-03-30 1991-07-02 Merrell Dow Pharmaceuticals Inc. Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
GB9303518D0 (en) * 1993-02-22 1993-04-07 Merrell Dow Pharma Combinations of retroviral inhibitors
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
ES2212292T3 (es) * 1997-05-22 2004-07-16 Aventis Pharmaceuticals Inc. Procedimiento para preparar 6-0-monoesteres de castanospermina.
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
KR20070053229A (ko) * 2004-08-13 2007-05-23 미게닉스 인코포레이티드 헤파드나비리대 감염을 치료 또는 예방하기 위한 조성물 및방법
KR20070061879A (ko) * 2004-10-06 2007-06-14 미게닉스 인코포레이티드 카스타노스페르민을 포함하는 조합 항-바이러스 조성물 및그의 사용 방법
KR20090040906A (ko) * 2006-08-02 2009-04-27 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 리포솜 치료
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
CN102427804A (zh) * 2009-03-27 2012-04-25 牛津大学之校长及学者 降低胆固醇水平的脂质体
WO2021168483A2 (en) 2020-02-21 2021-08-26 Florida State University Research Foundation, Inc. Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252962B1 (de) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulierung der retroviralen replikation, infektion und pathogenese
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis

Also Published As

Publication number Publication date
DE3850335T2 (de) 1994-10-13
AU2280288A (en) 1989-04-06
ATE107506T1 (de) 1994-07-15
KR890004701A (ko) 1989-05-09
IE64311B1 (en) 1995-07-26
ZA887160B (en) 1989-05-30
KR960009416B1 (en) 1996-07-19
JP2761898B2 (ja) 1998-06-04
AU614993B2 (en) 1991-09-19
JPH01106821A (ja) 1989-04-24
US5004746A (en) 1991-04-02
DK538888A (da) 1989-03-30
ES2058201T3 (es) 1994-11-01
EP0309952A3 (en) 1990-09-26
IE882933L (en) 1989-03-29
PH24431A (en) 1990-06-25
EP0309952B1 (de) 1994-06-22
DE3850335D1 (de) 1994-07-28
EP0309952A2 (de) 1989-04-05
DK538888D0 (da) 1988-09-28

Similar Documents

Publication Publication Date Title
DK172788B1 (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk præparat
JP4629104B2 (ja) ４−オキソキノリン誘導体および抗ｈｉｖ剤を含む併用剤
TWI328452B (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
KR101229528B1 (ko) 결정형 피리다진 화합물
JPH04253989A (ja) ９−プリニルホスホン酸誘導体
JP2720169B2 (ja) 抗レトロウイルス活性をもつ糖タンパク処理抑制剤
US5385911A (en) Anti-herpes castanospermine esters
EP0345751A1 (de) Antiretrovirale difluorierte Nucleoside
US5061715A (en) Prevention of glycoprotein enveloped virus infectivity by quinolyl- and isoquinolyloxazole-2-zones
EP0428105B1 (de) Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren
US5063238A (en) Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones
JP2911151B2 (ja) 抗レトロウィルスアリーロキシ置換フランケトン類
JP2927932B2 (ja) ピリジニルオキサゾール―２―オン類による糖蛋白エンベロープを着たウィルスの感染力の防止
AU621430B2 (en) Aroyloxy alkanols as anti-retrovirus agents
KR19990007796A (ko) 혈관 신생 억제제
EP0543555A1 (de) Phosphorylierte Flavonoide zur Behandlung von Viruserkrankungen
CN105936631A (zh) 3-(顺式)-乙烯芳基喹喔啉酮类似物、其制备方法和应用
NZ622558B2 (en) Hiv replication inhibitors
JPH06184153A (ja) 新規なフェノチアジン化合物及びその塩、それらの製法並びにそれらを有効成分とする消化性潰瘍治療剤
MXPA06010252A (en) Hiv integrase inhibitors

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK